Eubiotics Market to reach $14.6 billion by 2035

Eubiotics market was valued at $6.5 billion in 2025 and is projected to reach $14.6 billion by 2035, growing at a CAGR of 8.6% during the forecast period (2026-2035). The sustained increase in livestock production volumes is a primary structural factor supporting demand for eubiotics in animal nutrition. According to the Food and Agriculture Organization, global meat production reached approximately 374 million tonnes in 2024, reflecting continued growth in animal protein output driven by rising consumption patterns and population dynamics. Poultry alone accounts for nearly 40% of total meat production, highlighting its dominance within intensive farming systems where feed efficiency and gut health are critical performance parameters. This scale of production necessitates consistent improvements in feed conversion ratios and disease management practices, particularly in high-density farming environments. As livestock operations expand, producers are increasingly shifting toward functional feed additives that support digestive efficiency and reduce production risks. The structural growth in animal protein output directly translates into higher demand for scientifically formulated feed inputs, reinforcing the commercial relevance of eubiotics across major livestock categories.

Browse the full report description of “Eubiotics Market Size, Share & Trends Analysis Report by Type (Probiotics, Prebiotics, Exogenous Enzymes, Organic Acids, Essential Oils, and Others (Herbs and Polyphenols)), by Application (Feed Additives, Food & Beverages, and Dietary Supplements), by Animal Type (Poultry, Swine, Ruminants, Aquaculture, and Others), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/eubiotics-market

The relationship between livestock output and feed additive demand is further strengthened by intensification trends in modern farming systems. Data from the OECD–FAO Agricultural Outlook indicates that meat production continues to expand steadily, with 365 million tonnes recorded in 2024 and further incremental growth expected, particularly in poultry and emerging markets. This growth is accompanied by increasing pressure on producers to enhance productivity while maintaining cost efficiency, making feed optimization a central operational priority. In parallel, disease outbreaks such as avian influenza have affected over 173 million poultry birds in recent years, highlighting the need for preventive nutrition strategies that improve resilience and reduce dependency on therapeutic interventions. Eubiotics, including probiotics, organic acids, and phytogenic compounds, are increasingly incorporated into feed formulations to address these challenges in a commercially viable manner. As livestock production systems continue to scale and intensify, the adoption of such additives is expected to remain closely aligned with output growth, forming a core driver for market expansion.

Innovation Leaders Transforming the Eubiotics Market

The key players in the eubiotics market include Archer Daniels Midland Company, Cargill, Incorporated, BASF SE, DSM-Firmenich AG, Evonik Industries AG, among others. These companies are advancing innovation in animal nutrition through the development of scientifically engineered eubiotic solutions, including probiotics, prebiotics, enzymes, organic acids, and phytogenic additives, aimed at improving gut health, nutrient absorption, and overall livestock performance. Their efforts are focused on optimizing microbial balance and enhancing feed conversion efficiency, which remains critical for cost-effective and high-output animal production systems. Continuous investment in strain development, formulation technologies, and stability enhancement is enabling consistent product performance across varying environmental and processing conditions.

• In April 2024, DSM-Firmenich AG and Lallemand Health Solutions partnered to develop new synbiotic solutions for early-life nutrition. These combine human milk oligosaccharides (HMOs) with probiotics to support infant gut health, immune development, and overall growth. The aim is to make infant formula closer in function to breast milk by promoting a healthy microbiome. This collaboration reflects growing innovation in microbiome-based nutrition and expands the application of eubiotics beyond animal feed into human health segments.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
  • By Animal Type
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Archer Daniels Midland Company, Cargill, Incorporated, BASF SE, DSM-Firmenich AG, Evonik Industries AG, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Eubiotics Market Report Segment

By Type

• Probiotics
• Prebiotics
• Exogenous Enzymes
• Organic Acids
• Essential Oils
• Others (Herbs and Polyphenols)

By Application

• Feed Additives
• Food & Beverages
• Dietary Supplements

By Animal Type

• Poultry
• Swine
• Ruminants
• Aquaculture
• Others

Global Eubiotics Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/eubiotics-market